Colombia issues a compulsory license on patents for the HIV drug Dolutegravir
This is the 44 page decision: NC_534_Licencia_obligatoria_aceptada Arianna Schouten has a summary of the decision in English here: 23Apr2024-DecisionColombiaCLdolutegravir
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
